DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Atherosclerotic Cardiovascular Disease – Special Topic – Special Topics: Physician Insights on Current Treatment Practices and Emerging Therapies for ASCVD (US)
Atherosclerotic cardiovascular disease (ASCVD) is caused by plaque buildup in arterial walls. Clinical / established ASCVD consists of acute coronary syndromes, a history of myocardial infarction (…
Non-Alcoholic Steatohepatitis (NASH) | Disease Landscape and Forecast | G7 | 2022
The market for NASH, a severe form of nonalcoholic fatty liver disease (NAFLD), offers substantial commercial opportunity to drug developers owing to the lack of approved agents and the disease’s…
Nonalcoholic steatohepatitis | Treatment Algorithms: Claims Data Analysis | US | 2022
Nonalcoholic steatohepatitis (NASH) has the potential to be a large and lucrative therapy market owing to the prevalence of the disease and the lack of approved agents. Patients with NASH are at…
Congenital Heart Block – Executive Insights – Congenital Heart Block | Executive Insights | US/EU5 | 2022
Congenital heart block (CHB), also known as atrioventricular block, is a rare heart block disorder in which maternal antibodies attack the impulse-generating heart muscles of fetuses and newborns…
Primary Biliary Cholangitis | Treatment Algorithms: Claims Data Analysis | US | 2022
Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by inflammation, progressive damage, and, ultimately, destruction of the interlobular bile ducts; this process is…
